Structures by: Nowak I.
Total: 24
C35H33N5O8
C35H33N5O8
Organic letters (2006) 8, 20 4565-4568
a=10.9634(5)Å b=6.2492(3)Å c=24.2770(17)Å
α=90.00° β=97.714(3)° γ=90.00°
C8H9N5O2
C8H9N5O2
Organic letters (2006) 8, 20 4565-4568
a=6.9156(4)Å b=9.5678(6)Å c=14.8356(9)Å
α=90.00° β=97.897(2)° γ=90.00°
C11H15N5O5
C11H15N5O5
Organic letters (2006) 8, 20 4565-4568
a=6.1879(6)Å b=6.6386(6)Å c=30.879(3)Å
α=90.00° β=90.00° γ=90.00°
2,3-benzo-7,7-difluoro-1-(morpholin-4-yl)bicyclo[4.1.0]heptane hydrochloride
C15H18F2NO,Cl
Organic letters (2004) 6, 25 4767-4770
a=14.7787(8)Å b=11.8125(10)Å c=8.9824(5)Å
α=90.00° β=116.602(5)° γ=90.00°
2,3-benzo-7,7-difluoro-1-(morpholin-4-yl)bicyclo[4.1.0]heptane
C15H17F2NO
Organic letters (2004) 6, 25 4767-4770
a=9.6971(7)Å b=15.9100(17)Å c=8.8887(12)Å
α=90.00° β=107.646(9)° γ=90.00°
8,8-difluoro-1-(morpholin-4-yl)bicyclo[5.1.0]octane hydrochloride
C12H20F2NO,Cl
Organic letters (2004) 6, 25 4767-4770
a=9.0862(14)Å b=12.3385(19)Å c=11.885(3)Å
α=90.00° β=99.550(19)° γ=90.00°
9,9-difluoro-1-(morpholin-1-yl)bicyclo[6.1.0]nonane hydrobromide
C13H22F2NO,Br
Organic letters (2004) 6, 25 4767-4770
a=12.6119(8)Å b=7.2008(6)Å c=16.4798(13)Å
α=90.00° β=108.231(6)° γ=90.00°
7,7-difluoro-1-(morpholin-4-yl)bicyclo[4.1.0]heptane hydrochloride hydrate
C11H19F2NO1.50,Cl
Organic letters (2004) 6, 25 4767-4770
a=15.7559(9)Å b=12.6574(9)Å c=14.6957(12)Å
α=90.00° β=118.970(5)° γ=90.00°
C22H27N3O5
C22H27N3O5
Journal of medicinal chemistry (2007) 50, 16 3897-3905
a=6.6883(13)Å b=5.6677(11)Å c=27.611(6)Å
α=90.00° β=95.90(3)° γ=90.00°
C21H24N2O5
C21H24N2O5
Journal of medicinal chemistry (2007) 50, 16 3897-3905
a=6.6665(13)Å b=5.7707(12)Å c=25.533(5)Å
α=90.00° β=95.15(3)° γ=90.00°
6-(2-butylimidazol-1-yl)-2-chloropurine
C12H13ClN6
Journal of Organic Chemistry (2006) 71, 4216-4221
a=13.449(2)Å b=20.433(4)Å c=9.746(3)Å
α=90.00° β=107.333(2)° γ=90.00°
6-(1,2,4-triazol-4-yl)purine.pyridine
C12H10N8
Journal of Organic Chemistry (2006) 71, 4216-4221
a=28.454(6)Å b=12.209(2)Å c=7.1539(14)Å
α=90.00° β=95.85(3)° γ=90.00°
9-(5-O-acetyl-β-D-ribofuranosyl)-6-(imidazol-1-yl)purine
C15H16N6O5
Journal of Organic Chemistry (2006) 71, 4216-4221
a=8.6769(8)Å b=14.8384(14)Å c=25.297(2)Å
α=90.00° β=90.00° γ=90.00°
9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-2-chloro-6- (4,5-diphenylimidazol-1-yl)purine
C31H27ClN6O7
Journal of Organic Chemistry (2006) 71, 4216-4221
a=9.702(3)Å b=10.670(3)Å c=29.835(8)Å
α=90.00° β=90.00° γ=90.00°
9-(5-O-tert-butyldimethylsilyl-2,3-dideoxy-3-iodo- β-D-threo-pentofuranosyl)-6-(2,5-dimethylpyrrol-1-yl)purine
C22H32IN5O2Si
Journal of Organic Chemistry (2006) 71, 4216-4221
a=9.9025(17)Å b=13.0570(15)Å c=19.969(2)Å
α=90.00° β=90.00° γ=90.00°
C20H18F2N2O6
C20H18F2N2O6
Journal of Organic Chemistry (2006) 71, 8876-8883
a=12.0009(18)Å b=7.0164(10)Å c=12.796(2)Å
α=90.00° β=114.245(12)° γ=90.00°
C10H11F2N3O3
C10H11F2N3O3
Journal of Organic Chemistry (2006) 71, 8876-8883
a=5.3533(5)Å b=17.484(2)Å c=12.0785(12)Å
α=90.00° β=100.109(8)° γ=90.00°
C16H16F2N6O3
C16H16F2N6O3
Journal of Organic Chemistry (2006) 71, 8876-8883
a=7.2562(11)Å b=11.261(2)Å c=20.674(3)Å
α=90.00° β=90.00° γ=90.00°
C10H13N5O3
C10H13N5O3
Journal of Organic Chemistry (2007) 72, 8216-8221
a=7.6980(12)Å b=10.0638(15)Å c=14.166(2)Å
α=90.00° β=90.00° γ=90.00°
C10H10F2N2O4
C10H10F2N2O4
Journal of Organic Chemistry (2007) 72, 532-537
a=6.5347(6)Å b=7.0844(7)Å c=11.6550(11)Å
α=90.00° β=96.388(7)° γ=90.00°
C10H12BrF2N3O3
C10H12BrF2N3O3
Journal of Organic Chemistry (2007) 72, 532-537
a=6.4528(5)Å b=9.5514(7)Å c=20.5093(18)Å
α=90.00° β=90.00° γ=90.00°
C13H13BrO2
C13H13BrO2
Journal of Organic Chemistry (2007) 72, 2678-2681
a=8.1872(14)Å b=15.038(3)Å c=20.491(4)Å
α=90.00° β=90.00° γ=90.00°
C10H11F2N3O4
C10H11F2N3O4
Journal of Organic Chemistry (2007) 72, 3319-3325
a=6.2374(4)Å b=9.8577(10)Å c=18.1082(14)Å
α=90.00° β=90.00° γ=90.00°
C10H10F2N2O5
C10H10F2N2O5
Journal of Organic Chemistry (2007) 72, 3319-3325
a=6.9293(8)Å b=7.5038(11)Å c=10.7401(11)Å
α=90.00° β=93.891(7)° γ=90.00°